Cure My Disease

Don't miss your cure!

 Log in / Sign up

PBC drug combo safety check ends early

NCT ID NCT06488911

Terminated Disease control Sponsor: Intercept Pharmaceuticals Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at the long-term safety of a fixed-dose combination of two drugs (obeticholic acid and bezafibrate) for people with primary biliary cholangitis (PBC), a chronic liver disease. It enrolled 62 adults who had already been taking the combination in earlier studies. The study was terminated early, and its main goal was to track side effects, serious side effects, and changes in lab results. Because PBC requires ongoing treatment, this is classified as disease control, not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY BILIARY CHOLANGITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

primary biliary cholangitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PRIMARY BILIARY CHOLANGITIS

Contacts and locations

Locations

  • Academisch Medisch Centrum

    Amsterdam, 1005 AZ, Netherlands

  • Akershus University Hospital

    Lørenskog, 1478, Norway

  • American Research Corporation

    San Antonio, Texas, 78215, United States

  • Artroscan s.r.o. Gastroenterologicka

    Ostrava, 722100, Czechia

  • Azienda Ospedaliero-Universitaria di Bologna Policlinico S. Orsola-Malpighi

    Bologna, Italy

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, 02215, United States

  • CHRU de Lille

    Lille, 59000, France

  • CHU Paris Est - Hopital Saint Antoine

    Paris, 75012, France

  • Consorcio Hospital General Universitario

    Valencia, 46014, Spain

  • DEOEC II. sz. Belgygyszati Klinika

    Debrecen, 4032, Hungary

  • DIM Clinica Privada

    Buenos Aires, Argentina

  • East Tennessee Research Institute

    Johnson City, Tennessee, 37604, United States

  • Ege University, Faculty of Medicine, Gastroenterology

    Bornova, Turkey (Türkiye)

  • Flinders Medical Centre

    Bedford Park, 5042, Australia

  • Gastro One

    Germantown, Tennessee, 38138, United States

  • Hacettepe University, Faculty of Medicine, Adult Hospital Gastroenterology

    Ankara, Turkey (Türkiye)

  • Hadassah Ein-Karem Medical Center - Liver unit

    Jerusalem, 9112001, Israel

  • Harran University Hospital, Gastroenterology

    Sanliurfa, Turkey (Türkiye)

  • Hepato-Gastroenterologie HK, s.r.o.

    Hradec Králové, 50012, Czechia

  • Hopital Henri Mondor

    Créteil, 94000, France

  • Hopital de la Pitie Salpetriere

    Paris, 75013, France

  • Hospital ClinicUniversity of Barcelona

    Barcelona, 8036, Spain

  • Hospital Italiano de Buenos Aires

    Buenos Aires, Argentina

  • Hospital Italiano de La Plata

    Buenos Aires, Argentina

  • Hospital Provincial del Centenario

    Santa Fe, Argentina

  • Hospital Universitario Austral

    Buenos Aires, Argentina

  • Houston Methodist Hospital

    Houston, Texas, 77030, United States

  • Hull University Teaching Hospitals NHS Trust

    Hull, HU32JZ, United Kingdom

  • Institute of Cellular Medicine Newcastle University

    Newcastle upon Tyne, NE7 7DN, United Kingdom

  • Istanbul University, Capa Faculty of Medicine, Gastroenterology

    Istanbul, Turkey (Türkiye)

  • John Radcliffe Hospital

    Oxford, OX3 9DU, United Kingdom

  • Kyungpook National University Hospital

    Daegu, 41944, South Korea

  • Medizinische Hochschule Hannover

    Hanover, 30625, Germany

  • NYU Langone Health

    New York, New York, 10016, United States

  • Ochsner Clinic Foundation

    New Orleans, Louisiana, 70121, United States

  • Pacific Gastroenterology Associates GI Research Institute

    Vancouver, British Columbia, Canada

  • Piedmont Atlanta Hospital

    Atlanta, Georgia, 30309, United States

  • Research Site SRO

    Pilsen, 30100, Czechia

  • Royal Adelaide Hospital

    Adelaide, 5000, Australia

  • Seoul National University Bundang Hospital

    Seongnam-si, 463-707, South Korea

  • Southern California Research Center

    Coronado, California, 92118, United States

  • Tampa General Medical Group

    Tampa, Florida, 33606, United States

  • Tartu University Hospital

    Tartu, 50090, Estonia

  • The Liver Institute at Methodist Dallas Medical Center

    Dallas, Texas, 75203, United States

  • UZ Leuven

    Leuven, 3000, Belgium

  • University Hopital Santaros klinikos

    Vilnius, 8661, Lithuania

  • University Hospital of Larissa

    Larissa, 41110, Greece

  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, 44106, United States

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35233, United States

  • University of Alberta Division of Gastroenterology Zeidler Ledcor Centre

    Edmonton, Alberta, Canada

  • Universityl Hospital Dubrava

    Zagreb, 10 000, Croatia

More trials for these conditions

Other studies related to the condition(s) this trial covers.